U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
182731182731Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A PatientsCompletedNo Results AvailableHemophilia ADrug: Human Plasma-Derived Coagulation Factor VIII Concentrate (Virus Inactivated by Polysorbate 80 Treatment and Vapor Heat Treatment)https://ClinicalTrials.gov/show/NCT00162019
182732182732Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic PurpuraCompletedNo Results AvailableIdiopathic Thrombocytopenic PurpuraDrug: Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solutionhttps://ClinicalTrials.gov/show/NCT00162006
182733182733Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)CompletedNo Results AvailableHypogammaglobulinemia|Agammaglobulinemia|Primary Immunodeficiency (PID)Drug: Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution|Drug: Gammagard S/D (Solvent/Detergent)https://ClinicalTrials.gov/show/NCT00161993
182734182734Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection SitesCompletedNo Results AvailableBreast Cancer|Lumpectomy|Mastectomy Plus Axillary Lymph Node Dissection|Lymphatic LeakageDrug: Fibrin Sealant VH S/D|Procedure: Surgical intervention alone without Fibrin Sealant VH S/D applicationhttps://ClinicalTrials.gov/show/NCT00161980
182735182735TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)CompletedNo Results AvailableEncephalitis, Tick-BorneBiological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)https://ClinicalTrials.gov/show/NCT00161967
182736182736Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 YearsCompletedNo Results AvailableEncephalitis, Tick-borneBiological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)https://ClinicalTrials.gov/show/NCT00161954
182737182737Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216CompletedNo Results AvailableMeningococcal Meninigitis, Serogroup Chttps://ClinicalTrials.gov/show/NCT00161941
182738182738Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy InfantsCompletedNo Results AvailableMeningitis, MeningococcalBiological: Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT)https://ClinicalTrials.gov/show/NCT00161928
182739182739Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal VaricesCompletedNo Results AvailableEsophageal and/or Gastric VaricesDrug: Fibrin Sealanthttps://ClinicalTrials.gov/show/NCT00161915
182740182740Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip ReplacementCompletedNo Results AvailableHip Replacement SurgeryDrug: Fibrin Sealant Vapor-Heated Solvent/Detergent-treatedhttps://ClinicalTrials.gov/show/NCT00161902
182741182741FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 YearsCompletedNo Results AvailableEncephalitis, Tick-borneBiological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)https://ClinicalTrials.gov/show/NCT00161889
182742182742FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 YearsCompletedNo Results AvailableEncephalitis, Tick-borneBiological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)https://ClinicalTrials.gov/show/NCT00161876
182743182743Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 YearsCompletedNo Results AvailableTick-borne EncephalitisBiological: FSME-IMMUN NEW 0.25 mlhttps://ClinicalTrials.gov/show/NCT00161863
182744182744FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 YearsCompletedNo Results AvailableEncephalitis, Tick-borneBiological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)https://ClinicalTrials.gov/show/NCT00161850
182745182745Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004CompletedNo Results AvailableInfluenzaBiological: Vero Cell-derived Influenza Vaccine|Biological: Egg-derived Influenza Vaccinehttps://ClinicalTrials.gov/show/NCT00161837
182746182746Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPURCompletedNo Results AvailableEncephalitis, Tick-borneBiological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)https://ClinicalTrials.gov/show/NCT00161824
182747182747Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005CompletedNo Results AvailableInfluenzaBiological: Vero Cell-derived Influenza Vaccine|Biological: Egg cell-derived Influenza Vaccinehttps://ClinicalTrials.gov/show/NCT00161811
182748182748Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.CompletedNo Results AvailableTick-borne EncephalitisBiological: Tick-borne encephalitis vaccinehttps://ClinicalTrials.gov/show/NCT00161798
182749182749Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 YearsCompletedNo Results AvailableTick-borne EncephalitisBiological: FSME-IMMUN 0.5mlhttps://ClinicalTrials.gov/show/NCT00161785
182750182750Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.CompletedNo Results AvailableTick-borne EncephalitisBiological: Tick-borne Encephalitis Vaccinehttps://ClinicalTrials.gov/show/NCT00161772
182751182751Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn WoundsCompletedNo Results AvailableBurnsDrug: Sheet skin grafts affixed with Fibrin Sealant (lyophilized) with 4 IU/mL Thrombinhttps://ClinicalTrials.gov/show/NCT00161759
182752182752Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 YearsCompletedNo Results AvailableEncephalitis, Tick-borneBiological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)https://ClinicalTrials.gov/show/NCT00161746
182753182753Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac SurgeryCompletedNo Results AvailableCardiac Surgery Requiring Cardiopulmonary Bypass and Median SternotomyDrug: Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D)|Drug: TISSEEL VH fibrin sealanthttps://ClinicalTrials.gov/show/NCT00161733
182754182754Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use INDCompletedNo Results AvailableProtein C DeficiencyDrug: Protein C Concentrate (Human) Vapor Heatedhttps://ClinicalTrials.gov/show/NCT00161720
182755182755Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin DeficiencyCompletedNo Results AvailableAlpha 1-antitrypsin DeficiencyDrug: Aerosolized, Recombinant Alpha 1-Antitrypsinhttps://ClinicalTrials.gov/show/NCT00161707
182756182756Use of Sucrose to Relieve Pain During Eye Exams in InfantsTerminatedNo Results AvailableApnea of Prematurity|Retinopathy of Prematurity|PainDietary Supplement: sucrose solutionhttps://ClinicalTrials.gov/show/NCT00161694
182757182757Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMSCompletedNo Results AvailablePremenstrual SyndromeDrug: Levonorgestrel/Ethinyl Estradiolhttps://ClinicalTrials.gov/show/NCT00161681
182758182758Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual CareCompletedNo Results AvailableAcute Myeloid LeukemiaDrug: Mylotarghttps://ClinicalTrials.gov/show/NCT00161668
182759182759Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNo Results AvailablePsoriasis|Arthritis, PsoriaticDrug: Etanercept|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT00161655
182760182760Study Evaluating CMD-193 in Advanced Malignant Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: CMD-193https://ClinicalTrials.gov/show/NCT00161642

* Görseller ve İçerik tekif hakkına sahip olabilir